A quiet day for regulatory activity with 1 item tracked across 1 domain. Developments covered: MHRA consults on proposals to allow schools to keep spare adrenaline nasal sprays on site (Health Data, Medical Devices and Life Sciences, UK).
For you: Light regulatory activity today. Review the items below for any relevant updates.
How to read this digest
▼
Enforcement
Fines, sanctions, rulings
Legislation
New laws, statutory instruments
Consultation
Calls for evidence
Guidance
Frameworks, codes of practice
↔ Divergence
UK-EU moving apart
Regulatory signal
Risk, supervisory and policy signals
Commentary
Background, no action needed
Click a domain tile to expand, then click a category tag to see individual items.
An official website of the European Union How do you know? This site uses cookies. Visit our cookies policy page or click the link in any footer for more information and to change
On 14 May 2026, the CMA launched an investigation into whether Microsoft should be designated as having SMS in respect of its business software ecosystem . The proposed decision se
The MHRA has launched a consultation on proposals to permit schools to hold spare adrenaline nasal sprays on site as an additional emergency option for children at risk of anaphylaxis.